JP Morgan Maintains Overweight on HealthEquity, Lowers Price Target to $123

Benzinga Newsdesk www.benzinga.com Negative 83.8%

Neg 83.8% Neu 0% Pos 0%

JP Morgan analyst Alexei Gogolev maintains HealthEquity (NASDAQ:HQY) with a Overweight and lowers the price target from $129 to $123.